(Q36822506)

16 August 2017

1 reference

title

Evaluating the benefits and risks of postmenopausal hormone therapy (English)

1 reference

16 August 2017

S. R. Cummings

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1750410

15 November 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

16 August 2017

25 November 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1750410

full work available at URL

15 November 2022

https://api.elsevier.com/content/article/PII:000293439190241O?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

https://api.elsevier.com/content/article/PII:000293439190241O?httpAccept=text/plain

15 November 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

American Journal of Medicine

15 November 2022

published in

1 reference

16 August 2017

91

1 reference

16 August 2017

5B

1 reference

16 August 2017

14S-18S

1 reference

Benefits and risks of menopausal estrogen and/or progestin hormone use.

16 August 2017

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Estrogen modulates responses of atherosclerotic coronary arteries

15 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

15 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study

15 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

15 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Prevalence and determinants of estrogen replacement therapy in elderly women.

15 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Postmenopausal estrogen use and heart disease

15 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

15 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Lipoproteins and atherogenesis. Current concepts

15 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys

15 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Survival among women with endometrial cancer: a comparison of estrogen users and nonusers

15 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer

15 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy.

15 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Estrogen use and cardiovascular disease.

15 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered

15 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Women's and physicians' utilities for health outcomes in estrogen replacement therapy

15 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Should prescription of postmenopausal hormone therapy be based on the results of bone densitometry?

15 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy

15 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Menopausal estrogen use and the risk of breast cancer

15 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

The risk of breast cancer after estrogen and estrogen-progestin replacement

15 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

Menopausal oestrogens and breast cancer risk: an expanded case-control study

15 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90241-O

15 November 2022

Identifiers

1 reference

16 August 2017

1 reference